-
Value proposition
Developing Drugs that Target Individual Caspases to Fight Dementia and Inflammatory Diseases
IPCure is a pioneering biotech start-up dedicated to developing innovative treatments for neurodegenerative, metabolic, and inflammatory diseases. Our mission is to enhance the quality of life for patients worldwide by delivering groundbreaking treatments and paving the way towards curing these diseases.
IPCURE's expertise lies in targeting individual caspases to develop solutions addressing neurodegenerative and inflammatory diseases.
Through cutting-edge research and drug design, we aim to selectively target individual caspases, especially Caspase-2, to create effective therapeutic solutions. Our Flagship drug candidate targets Caspase-2, a crucial enzyme in memory function, to revolutionize the treatment of Frontotemporal Dementia (FTD) and Alzheimer's Disease (AD).
biotechnology, dementia, inflammation, Alzheimer's Disease, Frontotemporal dementia, Caspase-2, inflammatory Caspases, peptidomimetics, drug development, NASH, and MASH
-
IPCure
IPCure - Developing Drugs that Target Individual Caspases To Fight Dementia and Inflammatory Diseases
https://www.ipcure.life/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Réseau SATT
Research, Research (Auto) |
Réseau SATT
Research, Research (Auto) |
Other
7 Dec 2024 |
|
|